References
- Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm 2004; 282: 1–18
- Garti N, Avrahami M, Aserin A. Improved solubilization of celecoxib in U-type nonionic microemulsions and their structural transitions with progressive aqueous dilution. J Colloid Interface Sci 2006; 299: 352–365
- Graham D, Campen D, Hui R, Spence M, Cheetham C, Levy G, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: Nested control study. Lancet 2005; 365: 475–481
- Gupta P, Chawla G, Bansal AK. Physical stability and solubility advantage from amorphous celecoxib: The role of thermodynamic quantities and molecular mobility. Molec Pharmacol 2004; 1: 406–413
- Homar M, Šuligoj D, Gašperlin M. Preparation of microcapsules with self-microemulsifying core by a vibrating nozzle method. J Microencapsulation 2007; 24: 72–81
- Kas HS. Chitosan: Properties, preparations and application to microparticulate systems. J Microencapsulation 1997; 14: 689–711
- Koch S, Schwinger C, Kressler J, Heinzen Ch, Rainov NG. Alginate encapsulation of genetically engineered mammalian cells: Comparison of production devices, methods and microcapsule characteristics. J Microencapsulation 2003; 20: 303–316
- Nagarsenker MS, Joshi MS. Celecoxib–cyclodextrin systems: Characterization and evaluation of in vitro and in vivo advantage. Drug Dev Ind Pharm 2005; 31: 169–178
- Paulson SK, Vaughn MB, Jessen SM, Lawal Y, Gresk CJ, Yan B, et al. Pharmacokinetics of celecoxib after oral administration in dogs and humans: Effect of food and site of absorption. J Pharmacol Exp Ther 2001; 297: 638–645
- Porter CJ, Charman WN. In vitro assessment of oral lipid based formulations. Adv Drug Del Rev 2001; 50(Suppl 1)S127–147
- Seedher N, Bhatia S. Solubility enhancement of Cox-2 inhibitors using various solvent systems. AAPS Pharm Sci Tech 2003; 4: E33
- Serp D, Cantana E, Heinzen C, Von Stockar U, Marison IW. Characterization of an encapsulation device for the production of monodisperse alginate beads for cell immobilization. Biotechnol Bioeng 2000; 70: 41–53
- Subramanian N, Ray S, Ghosal SK, Bhadra R, Moulik SP. Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol Pharm Bull 2004; 12: 1993–1999
- Thakkar H, Sharma RK, Mishra AK, Chuttani K, Murthy RR. Albumin microspheres as carriers for the antiarthritic drug celecoxib. AAPS Pharm Sci Tech 2005; 6: E65–73